This topic contains a solution. Click here to go to the answer

Author Question: While preparing a patient about to undergo percutaneous umbilical cord blood sampling, which of the ... (Read 114 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
While preparing a patient about to undergo percutaneous umbilical cord blood sampling, which of the following information should the nurse provide as preprocedure teaching?
 
  Select all that apply.
  A)
  Once the procedure is begun, you must lie very still since they will be inserting a needle through the uterine wall.
  B)
  We will put you into the stirrups and dilate your cervix with a small catheter so that we can obtain a cord sample.
  C)
  During the procedure, an ultrasound will be utilized to guide the catheter into the correct position.
  D)
  We will send a sample of amniotic fluid to a regional medical center to have DNA tests performed for any genetic abnormality.

Question 2

While the nurse is educating a fellow nurse about some new research being developed to treat hepatitis C, specifically to identify disease-related drug targets on the cells, the nurse will be basing these data on which new technology finding?
 
  A)
  Recombinant DNA technology
  B)
  Haplotype mapping
  C)
  The human genome project
  D)
  Interference RNA (RNAi)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CharlieArnold

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

Ans:
A, C

Feedback:

PUBS is an invasive diagnostic procedure that involves the transcutaneous insertion of a needle through the uterine wall and into the umbilical artery. It is performed under ultrasound guidance and can be done any time after 16 weeks of gestation. Amniocentesis is the withdrawal of a sample of amniotic fluid for abnormal fetal screening as well as for chromosomal analysis. In chorionic villus sampling, the transcervical approach may be used (answer B).

Answer to Question 2

Ans:
D

Feedback:

Pharmaceutical companies are using RNAi to identify disease-related drug targets. There is considerable interest in harnessing RNAi for therapeutic purposes, linking the treatment of HIV infection and hepatitis C.




corkyiscool3328

  • Member
  • Posts: 539
Reply 2 on: Jun 25, 2018
Wow, this really help


pratush dev

  • Member
  • Posts: 321
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Your heart beats over 36 million times a year.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

For a complete list of videos, visit our video library